연구성과로 돌아가기
2024 연구성과별 연구자 정보 (112 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Adhesive-free PDMS/PUA bilayer using selective photopolymerization for transparent, attachable, and wearable triboelectric nanogenerator | Jeong, Hoon Eui | Jeong, HE | 7 | 교신저자 | Ulsan Natl Inst Sci & Technol UNIST, Dept Mech Engn, Ulsan 44919, South Korea | hoonejeong@unist.ac.kr;junyeob@knu.ac.kr; | ||||
| Adhesive-free PDMS/PUA bilayer using selective photopolymerization for transparent, attachable, and wearable triboelectric nanogenerator | Yeo, Junyeob | Yeo, JY | 8 | 교신저자 | Kyungpook Natl Univ, Dept Phys, Novel Appl Nano Opt Lab, 80 Daehak Ro, Daegu 41566, South Korea | I-1287-2013 | Yeo, Junyeob | 0000-0001-7422-3467 | Yeo, Junyeob | hoonejeong@unist.ac.kr;junyeob@knu.ac.kr; |
| Adhesive-free PDMS/PUA bilayer using selective photopolymerization for transparent, attachable, and wearable triboelectric nanogenerator | Yeo, Junyeob | Yeo, JY | 8 | 교신저자 | Kyungpook Natl Univ, Dept Hydrogen & Renewable Energy, 80 Daehak Ro, Daegu 41566, South Korea | I-1287-2013 | Yeo, Junyeob | 0000-0001-7422-3467 | Yeo, Junyeob | hoonejeong@unist.ac.kr;junyeob@knu.ac.kr; |
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Kang, Yoon-Koo | Kang, YK | 1 | Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea | ABL-4264-2022 | Kang, Yoon-Koo | msasako2010@yahoo.co.jp; | |||
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Terashima, Masanori | Terashima, M | 2 | Shizuoka Canc Ctr, Div Gastr Surg, Shizuoka, Japan | msasako2010@yahoo.co.jp; | |||||
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Kim, Young-Woo | Kim, YW | 3 | Natl Canc Ctr, Ctr Gastr Canc, Surg Dept, Goyang, South Korea | ABD-7016-2020 | Kim, Yuriy | msasako2010@yahoo.co.jp; | |||
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Boku, Narikazu | Boku, N | 4 | Univ Tokyo Hosp, Inst Med Sci, Dept Oncol & Gen Med, Tokyo, Japan | msasako2010@yahoo.co.jp; | |||||
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Chung, Hyun Cheol | Chung, HC | 5 | Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Seoul, South Korea | AFB-8969-2022 | Chung, Hyun Cheol | 0000-0002-0920-9471 | Chung, Hyun | msasako2010@yahoo.co.jp; | |
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Chen, Jen-Shi | Chen, JS | 6 | Chang Gung Univ, Linkou Chang Gung Mem Hosp, Dept Internal Med, Div Hematol & Oncol, Taoyuan, Taiwan | GLV-3349-2022 | Chen, Jen-Shi | msasako2010@yahoo.co.jp; | |||
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Ji, Jiafu | Ji, JF | 7 | Beijing Canc Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China | msasako2010@yahoo.co.jp; | |||||
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Yeh, Ta-Sen | Yeh, TS | 8 | Chang Gung Univ, Linkou Chang Gung Mem Hosp, Dept Surg, Taoyuan, Taiwan | msasako2010@yahoo.co.jp; | |||||
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Chen, Li-Tzong | Chen, LT | 9 | Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc Res, Kaohsiung, Taiwan | msasako2010@yahoo.co.jp; | |||||
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Chen, Li-Tzong | Chen, LT | 9 | Natl Cheng Kung Univ Hosp, Natl Cheng Kung Univ, Dept Internal Med, Tainan, Taiwan | msasako2010@yahoo.co.jp; | |||||
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Ryu, Min-Hee | Ryu, MH | 10 | Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea | msasako2010@yahoo.co.jp; | |||||
| Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial | Kim, Jong Gwang | Kim, JG | 11 | Kyungpook Natl Univ, Chilgok Hosp, Dept Hematooncol, Daegu, South Korea | msasako2010@yahoo.co.jp; |
페이지 이동: